首页 > 最新文献

Clinical Hypertension最新文献

英文 中文
Coffee intake and hypertension in Korean adults: results from KNHANES 2012-2016. 韩国成年人的咖啡摄入量与高血压:KNHANES 2012-2016的结果。
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-07-15 DOI: 10.1186/s40885-023-00239-4
Surabhi Shah, In-Jeong Cho, Whanhee Lee, Wook Bum Pyun, Eunhee Ha

Background: Coffee is the most popular and widely consumed drink in the world. Coffee consumption seems to have both benefits and risk with respect to hypertension; results from studies evaluating effect of frequency of coffee consumption on risk of hypertension are mixed and inconsistent. Hence, we investigated the association of coffee consumption and hypertension in Korean adults.

Methods: Data from Korean National Health and Nutrition Examination Survey (KNHANES) 2012-2016 was obtained and 12,133 eligible participants were selected. The coffee consumption was attained using a food frequency questionnaire. Subsequently coffee intake was grouped into two categories: ≤2 and > 2 servings per day. Hypertension status was defined as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, use of antihypertensive drug treatment, or both. Multivariable logistic regression analysis was used to examine the association of coffee consumption and hypertension.

Results: Logistic regression analysis showed that consumption of more than two servings of coffee a day was inversely associated with hypertension with odds ratio (OR) 0.84 (95% confidence interval [CI], 0.73-0.99). Similar results were seen in the propensity score-matched analysis (OR, 0.83; 95% CI, 0.69-0.98). Adults having age more than median value (OR, 0.76; 95% CI, 0.65-0.89) and normal cholesterol (OR, 0.84; 95% CI, 0.70-0.99) had significantly inverse association with hypertension, when coffee consumption was more than two servings daily.

Conclusions: More than two servings of coffee intake per day was inversely associated with hypertension as compared to consumption of ≤ 2 servings coffee per day.

背景:咖啡是世界上最受欢迎和广泛消费的饮料。喝咖啡似乎对高血压既有好处也有风险;评估咖啡饮用频率对高血压风险影响的研究结果是混合和不一致的。因此,我们调查了韩国成年人喝咖啡与高血压的关系。方法:获取2012-2016年韩国国家健康与营养调查(KNHANES)数据,选取12133名符合条件的参与者。咖啡的消费量是通过食物频率调查问卷获得的。随后将咖啡摄入量分为两类:每天≤2份和> 2份。高血压状态定义为收缩压≥140 mmHg或舒张压≥90 mmHg,使用抗高血压药物治疗,或两者兼而有之。采用多变量logistic回归分析来检验咖啡摄入量与高血压的关系。结果:Logistic回归分析显示,每天饮用超过两份咖啡与高血压呈负相关,比值比(OR)为0.84(95%可信区间[CI], 0.73-0.99)。在倾向评分匹配分析中也看到了类似的结果(OR, 0.83;95% ci, 0.69-0.98)。年龄大于中位数的成年人(OR, 0.76;95% CI, 0.65-0.89)和正常胆固醇(OR, 0.84;95% CI, 0.70-0.99)与高血压呈显著负相关,当每天喝咖啡超过两份时。结论:与每天摄入≤2杯咖啡相比,每天摄入超过2杯咖啡与高血压呈负相关。
{"title":"Coffee intake and hypertension in Korean adults: results from KNHANES 2012-2016.","authors":"Surabhi Shah,&nbsp;In-Jeong Cho,&nbsp;Whanhee Lee,&nbsp;Wook Bum Pyun,&nbsp;Eunhee Ha","doi":"10.1186/s40885-023-00239-4","DOIUrl":"https://doi.org/10.1186/s40885-023-00239-4","url":null,"abstract":"<p><strong>Background: </strong>Coffee is the most popular and widely consumed drink in the world. Coffee consumption seems to have both benefits and risk with respect to hypertension; results from studies evaluating effect of frequency of coffee consumption on risk of hypertension are mixed and inconsistent. Hence, we investigated the association of coffee consumption and hypertension in Korean adults.</p><p><strong>Methods: </strong>Data from Korean National Health and Nutrition Examination Survey (KNHANES) 2012-2016 was obtained and 12,133 eligible participants were selected. The coffee consumption was attained using a food frequency questionnaire. Subsequently coffee intake was grouped into two categories: ≤2 and > 2 servings per day. Hypertension status was defined as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, use of antihypertensive drug treatment, or both. Multivariable logistic regression analysis was used to examine the association of coffee consumption and hypertension.</p><p><strong>Results: </strong>Logistic regression analysis showed that consumption of more than two servings of coffee a day was inversely associated with hypertension with odds ratio (OR) 0.84 (95% confidence interval [CI], 0.73-0.99). Similar results were seen in the propensity score-matched analysis (OR, 0.83; 95% CI, 0.69-0.98). Adults having age more than median value (OR, 0.76; 95% CI, 0.65-0.89) and normal cholesterol (OR, 0.84; 95% CI, 0.70-0.99) had significantly inverse association with hypertension, when coffee consumption was more than two servings daily.</p><p><strong>Conclusions: </strong>More than two servings of coffee intake per day was inversely associated with hypertension as compared to consumption of ≤ 2 servings coffee per day.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"29 1","pages":"20"},"PeriodicalIF":4.2,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9824042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantitative measurement of empathy and analysis of its correlation to clinical factors in korean patients with chronic diseases. 韩国慢性疾病患者共情能力的定量测量及其与临床因素的相关性分析。
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-07-15 DOI: 10.1186/s40885-023-00246-5
Ran Heo, Jinho Shin, Byung Sik Kim, Hyun-Jin Kim, Kye-Yeung Park, Hoon-Ki Park, Yu Mi Kim, Seon Young Hwang, Stewart W Mercer

Background: Empathy is the core of the physician-patient relationship. The Consultation and Relational Empathy (CARE) measure is a useful tool for assessing patient-rated empathy. There have been scarce data on empathy in chronic disease patients in Korea. We aim to evaluate empathy using the Korean CARE measure in patients from various clinical environments and the factors influencing the degree of empathy in patients with chronic disease.

Methods: Data were collected from patients with chronic diseases. Patients were from primary, secondary, and tertiary clinics. Characteristics of the patients, physicians, and disease status were collected. The difference in CARE score was studied according to the clinical factors.

Results: A total of 162 patients with chronic diseases were included. About 60% of patients were male. The mean age was 62 years. They had an average number of 2.6 diseases. More than half of patients experienced overt cardiovascular disease. About half of them had a history of hospitalization due to cardiovascular disease. The overall average CARE score was 45.6 ± 7.0. The CARE score was not significantly different according to the characteristics of the patient, physician, or disease status. Regarding marital status, the CARE score was significantly lower for the small number of patients (n = 4, 2.5%) who refused to provide their marital status than for other groups. Except for four patients, there was no significant difference in the CARE score among married, unmarried, or divorced groups. This trend was maintained in hypertensive patients.

Conclusions: The Korean CARE measure could assess patient-rated empathy in various clinical practices. The empathy of patients was high regardless of multiple factors.

背景:共情是医患关系的核心。咨询和关系共情(CARE)测量是评估患者共情的有用工具。在韩国,关于慢性疾病患者的同理心的数据很少。本研究旨在利用韩国CARE量表评估不同临床环境患者的共情能力,并探讨影响慢性疾病患者共情能力的因素。方法:收集慢性疾病患者资料。患者来自初级、二级和三级诊所。收集患者、医生和疾病状况的特征。根据临床因素分析CARE评分的差异。结果:共纳入162例慢性疾病患者。约60%的患者为男性。平均年龄为62岁。他们平均有2.6种疾病。超过一半的患者有明显的心血管疾病。其中约一半有因心血管疾病住院的病史。总体平均CARE评分为45.6±7.0分。根据患者、医生或疾病状态的特征,CARE评分没有显著差异。关于婚姻状况,少数拒绝提供婚姻状况的患者(n = 4,2.5%)的CARE评分明显低于其他组。除4例患者外,已婚、未婚、离婚组的CARE评分均无显著差异。这一趋势在高血压患者中保持不变。结论:韩国的CARE量表可以在不同的临床实践中评估患者评定的共情。无论多种因素如何,患者的共情程度都很高。
{"title":"Quantitative measurement of empathy and analysis of its correlation to clinical factors in korean patients with chronic diseases.","authors":"Ran Heo,&nbsp;Jinho Shin,&nbsp;Byung Sik Kim,&nbsp;Hyun-Jin Kim,&nbsp;Kye-Yeung Park,&nbsp;Hoon-Ki Park,&nbsp;Yu Mi Kim,&nbsp;Seon Young Hwang,&nbsp;Stewart W Mercer","doi":"10.1186/s40885-023-00246-5","DOIUrl":"https://doi.org/10.1186/s40885-023-00246-5","url":null,"abstract":"<p><strong>Background: </strong>Empathy is the core of the physician-patient relationship. The Consultation and Relational Empathy (CARE) measure is a useful tool for assessing patient-rated empathy. There have been scarce data on empathy in chronic disease patients in Korea. We aim to evaluate empathy using the Korean CARE measure in patients from various clinical environments and the factors influencing the degree of empathy in patients with chronic disease.</p><p><strong>Methods: </strong>Data were collected from patients with chronic diseases. Patients were from primary, secondary, and tertiary clinics. Characteristics of the patients, physicians, and disease status were collected. The difference in CARE score was studied according to the clinical factors.</p><p><strong>Results: </strong>A total of 162 patients with chronic diseases were included. About 60% of patients were male. The mean age was 62 years. They had an average number of 2.6 diseases. More than half of patients experienced overt cardiovascular disease. About half of them had a history of hospitalization due to cardiovascular disease. The overall average CARE score was 45.6 ± 7.0. The CARE score was not significantly different according to the characteristics of the patient, physician, or disease status. Regarding marital status, the CARE score was significantly lower for the small number of patients (n = 4, 2.5%) who refused to provide their marital status than for other groups. Except for four patients, there was no significant difference in the CARE score among married, unmarried, or divorced groups. This trend was maintained in hypertensive patients.</p><p><strong>Conclusions: </strong>The Korean CARE measure could assess patient-rated empathy in various clinical practices. The empathy of patients was high regardless of multiple factors.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"29 1","pages":"19"},"PeriodicalIF":4.2,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9824043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Arterial hypertension in Leigh syndrome due to m.13513G > A is multicausal, requiring an extensive search to identify its pathphysiology. 由m.13513G > A引起的Leigh综合征动脉高血压是多原因的,需要广泛的研究来确定其病理生理学。
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-07-01 DOI: 10.1186/s40885-023-00247-4
Josef Finsterer
{"title":"Arterial hypertension in Leigh syndrome due to m.13513G > A is multicausal, requiring an extensive search to identify its pathphysiology.","authors":"Josef Finsterer","doi":"10.1186/s40885-023-00247-4","DOIUrl":"https://doi.org/10.1186/s40885-023-00247-4","url":null,"abstract":"","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"29 1","pages":"18"},"PeriodicalIF":4.2,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9743804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges of managing hypertension in Pakistan - a review. 巴基斯坦管理高血压的挑战——综述。
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-06-15 DOI: 10.1186/s40885-023-00245-6
Adil Elahi, Arzina Aziz Ali, Aamir Hameed Khan, Zainab Samad, Hunaina Shahab, Namra Aziz, Aysha Almas

Background: This review aims to describe existing evidence on the state of hypertension in Pakistan, including the prevalence, associated risk factors, preventive strategies, and challenges in the management of hypertension.

Methods: A comprehensive literature search was conducted electronically using PubMed and Google Scholar. Using specific screening methodology, 55 articles were selected to be included.

Results: We found from this extensive review that several small studies report high prevalence of hypertension but there is a lack of population based prevalence of hypertension in Pakistan. Lifestyle risk factors such as obesity, unhealthy diet, decreased physical activity, low socioeconomic status, and lack of access to care were the main associated factors with hypertension. Lack of blood pressure monitoring practices and medication non-adherence were also linked to uncontrolled hypertension in Pakistan and were more evident in primary care setups. The evidence presented is essential for delineating the burden of the disease, hence allowing for better management of this underserved population.

Conclusion: There is a need for updated surveys to depict the true prevalence and management of hypertension in Pakistan. Cost-effective implementation strategies and policies at the national level are needed for both prevention and control of hypertension.

背景:本综述旨在描述巴基斯坦高血压状况的现有证据,包括患病率、相关危险因素、预防策略和高血压管理中的挑战。方法:利用PubMed和Google Scholar进行全面的电子文献检索。采用特定的筛选方法,选择55篇文章纳入。结果:我们从这项广泛的综述中发现,几项小型研究报告了高血压的高患病率,但在巴基斯坦缺乏以人口为基础的高血压患病率。生活方式风险因素,如肥胖、不健康饮食、体力活动减少、低社会经济地位和缺乏护理是高血压的主要相关因素。在巴基斯坦,缺乏血压监测实践和药物依从性也与高血压不受控制有关,这在初级保健机构中更为明显。所提出的证据对于描述疾病负担至关重要,从而能够更好地管理这一服务不足的人群。结论:有必要进行更新的调查,以描述巴基斯坦高血压的真实患病率和管理。预防和控制高血压需要国家一级具有成本效益的实施战略和政策。
{"title":"Challenges of managing hypertension in Pakistan - a review.","authors":"Adil Elahi,&nbsp;Arzina Aziz Ali,&nbsp;Aamir Hameed Khan,&nbsp;Zainab Samad,&nbsp;Hunaina Shahab,&nbsp;Namra Aziz,&nbsp;Aysha Almas","doi":"10.1186/s40885-023-00245-6","DOIUrl":"https://doi.org/10.1186/s40885-023-00245-6","url":null,"abstract":"<p><strong>Background: </strong>This review aims to describe existing evidence on the state of hypertension in Pakistan, including the prevalence, associated risk factors, preventive strategies, and challenges in the management of hypertension.</p><p><strong>Methods: </strong>A comprehensive literature search was conducted electronically using PubMed and Google Scholar. Using specific screening methodology, 55 articles were selected to be included.</p><p><strong>Results: </strong>We found from this extensive review that several small studies report high prevalence of hypertension but there is a lack of population based prevalence of hypertension in Pakistan. Lifestyle risk factors such as obesity, unhealthy diet, decreased physical activity, low socioeconomic status, and lack of access to care were the main associated factors with hypertension. Lack of blood pressure monitoring practices and medication non-adherence were also linked to uncontrolled hypertension in Pakistan and were more evident in primary care setups. The evidence presented is essential for delineating the burden of the disease, hence allowing for better management of this underserved population.</p><p><strong>Conclusion: </strong>There is a need for updated surveys to depict the true prevalence and management of hypertension in Pakistan. Cost-effective implementation strategies and policies at the national level are needed for both prevention and control of hypertension.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"29 1","pages":"17"},"PeriodicalIF":4.2,"publicationDate":"2023-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9692986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between D-dimer and long-term mortality in patients with acute severe hypertension visiting the emergency department. 急诊科急性重症高血压患者d -二聚体与长期死亡率的关系
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-06-15 DOI: 10.1186/s40885-023-00244-7
Byung Sik Kim, Jeong-Hun Shin

Objective: High levels of D-dimer, a marker of thrombotic events, are associated with poor outcomes in patients with various cardiovascular diseases. However, there has been no research on its prognostic implications in acute severe hypertension. This study investigated the association between D-dimer levels and long-term mortality in patients with severe acute hypertension who visited the emergency department.

Design and method: This observational study included patients with acute severe hypertension who visited the emergency department between 2016 and 2019. Acute severe hypertension was defined as a systolic blood pressure ≥ 180 mmHg or a diastolic blood pressure ≥ 100 mmHg. Among the 10,219 patients, 4,127 who underwent D-dimer assay were analyzed. The patients were categorized into tertiles based on their D-dimer levels at the time of emergency department admission.

Results: Among the 4,127 patients with acute severe hypertension, 3.1% in the first (lowest) tertile, 17.0% in the second tertile, and 43.2% in the third (highest) tertile died within 3 years. After the adjustment for confounding variables, the third tertile of the D-dimer group (hazard ratio, 6.440; 95% confidence interval, 4.628-8.961) and the second tertile of the D-dimer group (hazard ratio, 2.847; 95% confidence interval, 2.037-3.978) had a significantly higher risk of all-cause mortality over 3 years than the first tertile of the D-dimer group.

Conclusions: D-dimer may be a useful marker for identifying the risk of mortality among patients with acute severe hypertension who visit the emergency department.

目的:高水平的d -二聚体(血栓事件的标志物)与各种心血管疾病患者的不良预后相关。然而,目前尚无关于其对急性重度高血压预后影响的研究。本研究调查了急诊重症急性高血压患者d -二聚体水平与长期死亡率之间的关系。设计与方法:本观察性研究纳入2016年至2019年急诊就诊的急性重度高血压患者。急性重度高血压定义为收缩压≥180 mmHg或舒张压≥100 mmHg。在10219例患者中,4127例接受了d -二聚体检测。根据患者在急诊室入院时的d -二聚体水平将患者分为四组。结果:4127例急性重度高血压患者中,第一组(最低)3.1%,第二组(17.0%),第三组(最高)43.2%在3年内死亡。校正混杂变量后,d -二聚体组第三分位数(风险比,6.440;95%可信区间,4.628-8.961)和d -二聚体组的第二分位数(风险比,2.847;95%可信区间为2.037 ~ 3.978),3年全因死亡率明显高于d -二聚体组的前1分位数。结论:d -二聚体可能是识别急诊科急性重症高血压患者死亡风险的有用标志物。
{"title":"Association between D-dimer and long-term mortality in patients with acute severe hypertension visiting the emergency department.","authors":"Byung Sik Kim,&nbsp;Jeong-Hun Shin","doi":"10.1186/s40885-023-00244-7","DOIUrl":"https://doi.org/10.1186/s40885-023-00244-7","url":null,"abstract":"<p><strong>Objective: </strong>High levels of D-dimer, a marker of thrombotic events, are associated with poor outcomes in patients with various cardiovascular diseases. However, there has been no research on its prognostic implications in acute severe hypertension. This study investigated the association between D-dimer levels and long-term mortality in patients with severe acute hypertension who visited the emergency department.</p><p><strong>Design and method: </strong>This observational study included patients with acute severe hypertension who visited the emergency department between 2016 and 2019. Acute severe hypertension was defined as a systolic blood pressure ≥ 180 mmHg or a diastolic blood pressure ≥ 100 mmHg. Among the 10,219 patients, 4,127 who underwent D-dimer assay were analyzed. The patients were categorized into tertiles based on their D-dimer levels at the time of emergency department admission.</p><p><strong>Results: </strong>Among the 4,127 patients with acute severe hypertension, 3.1% in the first (lowest) tertile, 17.0% in the second tertile, and 43.2% in the third (highest) tertile died within 3 years. After the adjustment for confounding variables, the third tertile of the D-dimer group (hazard ratio, 6.440; 95% confidence interval, 4.628-8.961) and the second tertile of the D-dimer group (hazard ratio, 2.847; 95% confidence interval, 2.037-3.978) had a significantly higher risk of all-cause mortality over 3 years than the first tertile of the D-dimer group.</p><p><strong>Conclusions: </strong>D-dimer may be a useful marker for identifying the risk of mortality among patients with acute severe hypertension who visit the emergency department.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"29 1","pages":"16"},"PeriodicalIF":4.2,"publicationDate":"2023-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268450/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9995527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility, credence, and usefulness of out-of-office cuffless blood pressure monitoring using smartwatch: a population survey. 使用智能手表进行办公室外无袖带血压监测的可行性、可信度和实用性:一项人口调查。
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-06-01 DOI: 10.1186/s40885-023-00242-9
Yongjun Jang, Jong-Mo Seo, Sang-Hyun Ihm, Hae Young Lee

Background: Cuffless blood pressure (BP) measurement, enabled by recent advances in wearable devices, allows for BP monitoring in daily life. This study aims to evaluate the feasibility, cresdence, and usefulness of cuffless BP monitoring through a population survey.

Methods: During the "Daily BP Measurement with Your Galaxy Watch" campaign held by the Korean Society of Hypertension, participants were asked to share their experiences with cuffless BP measurement using a smartwatch application through an online survey. The questionnaire included questions about age, underlying medical conditions, smartwatch utilization, experience with BP calibration, the reliability of BP values measured by a smartwatch, and willingness to use the BP monitoring function in the future.

Results: A total of 1071 participants responded to the survey. The largest age group (decile) was 50-59 years old (33.3%), followed by 40-49 years old (29.9%). Although nearly half of the participants (47.5%) had no chronic diseases, 40.1% reported having hypertension. BP monitoring was the most frequently utilized smartwatch function (95.8%), followed by heart rate measurement (87.1%). 31.8% of participants reported that BP values measured by the smartphone application were "very accurate and helpful," while 63.5% rated them as "slightly lower (44.4%)" or "higher (19.1%)" compared to the standard home BP monitoring device. 93% of the participants reported utilizing the BP monitoring function at least once a week. Regarding the BP calibration process, most participants (93.9%) calibrated the BP measurement application themselves, and 50.8% rated the difficulty level as "very easy."

Conclusion: Cuffless BP measurement using a smartwatch application was feasible in the general population, including the self-calibration process. However, the satisfaction level in terms of accuracy is still modest, indicating a need for further development.

背景:可穿戴设备的最新进展使无袖带血压(BP)测量成为可能,使日常生活中的血压监测成为可能。本研究旨在通过人口调查评估无袖血压监测的可行性、重要性和实用性。方法:在韩国高血压学会举办的“用你的Galaxy Watch测量每日血压”活动中,参与者通过在线调查分享他们使用智能手表应用程序进行无袖扣血压测量的经验。问卷内容包括年龄、潜在医疗状况、智能手表使用情况、血压校准经验、智能手表测量血压值的可靠性以及未来使用血压监测功能的意愿。结果:共有1071名参与者回应了调查。50-59岁是最大的年龄组(33.3%),其次是40-49岁(29.9%)。虽然近一半的参与者(47.5%)没有慢性疾病,但40.1%的人报告患有高血压。血压监测是智能手表最常用的功能(95.8%),其次是心率测量(87.1%)。31.8%的参与者报告说,智能手机应用程序测量的血压值“非常准确和有用”,而63.5%的人认为与标准的家用血压监测设备相比,它们“略低(44.4%)”或“略高(19.1%)”。93%的参与者报告每周至少使用一次血压监测功能。在血压校准过程中,大多数参与者(93.9%)自己校准了血压测量应用程序,50.8%的参与者认为难度级别为“非常容易”。结论:在普通人群中,使用智能手表进行无袖扣血压测量是可行的,包括自校准过程。然而,在准确性方面的满意程度仍然是适度的,表明需要进一步的发展。
{"title":"Feasibility, credence, and usefulness of out-of-office cuffless blood pressure monitoring using smartwatch: a population survey.","authors":"Yongjun Jang,&nbsp;Jong-Mo Seo,&nbsp;Sang-Hyun Ihm,&nbsp;Hae Young Lee","doi":"10.1186/s40885-023-00242-9","DOIUrl":"https://doi.org/10.1186/s40885-023-00242-9","url":null,"abstract":"<p><strong>Background: </strong>Cuffless blood pressure (BP) measurement, enabled by recent advances in wearable devices, allows for BP monitoring in daily life. This study aims to evaluate the feasibility, cresdence, and usefulness of cuffless BP monitoring through a population survey.</p><p><strong>Methods: </strong>During the \"Daily BP Measurement with Your Galaxy Watch\" campaign held by the Korean Society of Hypertension, participants were asked to share their experiences with cuffless BP measurement using a smartwatch application through an online survey. The questionnaire included questions about age, underlying medical conditions, smartwatch utilization, experience with BP calibration, the reliability of BP values measured by a smartwatch, and willingness to use the BP monitoring function in the future.</p><p><strong>Results: </strong>A total of 1071 participants responded to the survey. The largest age group (decile) was 50-59 years old (33.3%), followed by 40-49 years old (29.9%). Although nearly half of the participants (47.5%) had no chronic diseases, 40.1% reported having hypertension. BP monitoring was the most frequently utilized smartwatch function (95.8%), followed by heart rate measurement (87.1%). 31.8% of participants reported that BP values measured by the smartphone application were \"very accurate and helpful,\" while 63.5% rated them as \"slightly lower (44.4%)\" or \"higher (19.1%)\" compared to the standard home BP monitoring device. 93% of the participants reported utilizing the BP monitoring function at least once a week. Regarding the BP calibration process, most participants (93.9%) calibrated the BP measurement application themselves, and 50.8% rated the difficulty level as \"very easy.\"</p><p><strong>Conclusion: </strong>Cuffless BP measurement using a smartwatch application was feasible in the general population, including the self-calibration process. However, the satisfaction level in terms of accuracy is still modest, indicating a need for further development.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"29 1","pages":"15"},"PeriodicalIF":4.2,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9568764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic roles of thiazides and loop diuretics in blood pressure control and renal protection against chronic kidney disease. 噻嗪类和环状利尿剂在控制血压和预防慢性肾脏疾病中的治疗作用。
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-05-15 DOI: 10.1186/s40885-023-00238-5
Wonji Jo, Eun Sil Koh, Sungjin Chung

Fluid overload secondary to loss of functional nephron mass can elevate blood pressure, which is characteristic of hypertension shown in chronic kidney disease (CKD). Therefore, it is logical to use diuretics at appropriate dose to lower blood pressure in patients with CKD and hypertension. Despite the theoretical background on the use of diuretics in CKD, there have been no definitive data on the effectiveness or safety of diuretics as first-line therapy for the management of hypertension in patients with CKD. Results from some clinical trials have demonstrated that diuretics would not lower blood pressure. They could even worsen electrolyte imbalance and kidney function when they are administered in patients with CKD. Major clinical practice guidelines on management of blood pressure or CKD have stated that evidence for benefits of thiazide diuretics is not conclusive yet in patients with advanced CKD, although loop diuretics are often effective for volume control at lower glomerular filtration rate. Recently, evidence for diuretics as effective blood pressure lowering agents in patients with advanced CKD is increasing. Renoprotective effect of thiazide or loop diuretics might represent a consequence of their influence on blood pressure or their ability to potentiate the effect of renin-angiotensin system blockade by making intraglomerular pressure more renin-angiotensin system-dependent, although their direct benefit on renal function remains controversial. This review summarizes recent data on the possible role of diuretics in lowering blood pressure, slowing the progression of kidney disease, and reducing cardiovascular risk in CKD patients.

继发于功能性肾单位质量丧失的液体超载可使血压升高,这是慢性肾脏疾病(CKD)中高血压的特征。因此,在CKD合并高血压患者中使用适当剂量的利尿剂来降低血压是合乎逻辑的。尽管在CKD中使用利尿剂有一定的理论背景,但利尿剂作为一线治疗CKD高血压患者的有效性和安全性尚无明确的数据。一些临床试验的结果表明,利尿剂不会降低血压。当慢性肾病患者服用这些药物时,它们甚至会加重电解质失衡和肾功能。高血压或慢性肾病管理的主要临床实践指南已经表明,噻嗪类利尿剂对晚期慢性肾病患者有益的证据尚不明确,尽管在肾小球滤过率较低时,循环利尿剂通常对体积控制有效。最近,利尿剂作为晚期CKD患者有效降血压药物的证据越来越多。噻嗪类或环状利尿剂的肾保护作用可能是由于它们对血压的影响,或它们通过使肾小球内压力更加依赖肾素血管紧张素系统而增强肾素血管紧张素系统阻断作用的能力,尽管它们对肾功能的直接益处仍有争议。这篇综述总结了利尿剂在降低CKD患者血压、减缓肾脏疾病进展和降低心血管风险方面的可能作用。
{"title":"Therapeutic roles of thiazides and loop diuretics in blood pressure control and renal protection against chronic kidney disease.","authors":"Wonji Jo,&nbsp;Eun Sil Koh,&nbsp;Sungjin Chung","doi":"10.1186/s40885-023-00238-5","DOIUrl":"https://doi.org/10.1186/s40885-023-00238-5","url":null,"abstract":"<p><p>Fluid overload secondary to loss of functional nephron mass can elevate blood pressure, which is characteristic of hypertension shown in chronic kidney disease (CKD). Therefore, it is logical to use diuretics at appropriate dose to lower blood pressure in patients with CKD and hypertension. Despite the theoretical background on the use of diuretics in CKD, there have been no definitive data on the effectiveness or safety of diuretics as first-line therapy for the management of hypertension in patients with CKD. Results from some clinical trials have demonstrated that diuretics would not lower blood pressure. They could even worsen electrolyte imbalance and kidney function when they are administered in patients with CKD. Major clinical practice guidelines on management of blood pressure or CKD have stated that evidence for benefits of thiazide diuretics is not conclusive yet in patients with advanced CKD, although loop diuretics are often effective for volume control at lower glomerular filtration rate. Recently, evidence for diuretics as effective blood pressure lowering agents in patients with advanced CKD is increasing. Renoprotective effect of thiazide or loop diuretics might represent a consequence of their influence on blood pressure or their ability to potentiate the effect of renin-angiotensin system blockade by making intraglomerular pressure more renin-angiotensin system-dependent, although their direct benefit on renal function remains controversial. This review summarizes recent data on the possible role of diuretics in lowering blood pressure, slowing the progression of kidney disease, and reducing cardiovascular risk in CKD patients.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"29 1","pages":"14"},"PeriodicalIF":4.2,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9476671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Suboptimal control status of young hypertensive population. 青年高血压人群的次优控制状况。
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-05-01 DOI: 10.1186/s40885-023-00237-6
Donghun Shin, JungMin Choi, Hae-Young Lee

The prevalence of hypertension (HT) among young adults aged 18 to 39 years is estimated to be 3.7% to 8.6% worldwide. Although the prevalence of HT in young adults is lower than that of the overall population, those with HT are at substantially increased risk of cardiovascular events compared to those without HT. HT in young adults should be taken with even more caution as longer exposure to higher blood pressure leads to a higher lifetime risk of HT-mediated organ damage. However, young patients with HT show low awareness of HT compared to older patients. Also, they are more prone to show low treatment adherence despite the good efficacy of the treatment. Other risk factors that hinder HT control among young adults include alcohol intake, smoking, low physical activity, emotional stress, job stress, metabolic syndrome, and obesity. This review aimed to illustrate the suboptimal control status of the young hypertensive population and to propose strategies for improvement.

据估计,全世界18至39岁年轻人中高血压(HT)的患病率为3.7%至8.6%。虽然年轻成人中HT的患病率低于总体人群,但与没有HT的人相比,患有HT的人患心血管事件的风险明显增加。年轻成人应更加谨慎地使用HT,因为长期暴露于较高的血压会导致HT介导的器官损伤的终生风险更高。然而,与老年患者相比,年轻HT患者对HT的认知度较低。此外,尽管治疗效果良好,但他们更容易表现出较低的治疗依从性。其他阻碍年轻人控制HT的危险因素包括饮酒、吸烟、体力活动少、情绪压力、工作压力、代谢综合征和肥胖。本综述旨在阐明青年高血压人群的次优控制状态,并提出改善策略。
{"title":"Suboptimal control status of young hypertensive population.","authors":"Donghun Shin,&nbsp;JungMin Choi,&nbsp;Hae-Young Lee","doi":"10.1186/s40885-023-00237-6","DOIUrl":"https://doi.org/10.1186/s40885-023-00237-6","url":null,"abstract":"<p><p>The prevalence of hypertension (HT) among young adults aged 18 to 39 years is estimated to be 3.7% to 8.6% worldwide. Although the prevalence of HT in young adults is lower than that of the overall population, those with HT are at substantially increased risk of cardiovascular events compared to those without HT. HT in young adults should be taken with even more caution as longer exposure to higher blood pressure leads to a higher lifetime risk of HT-mediated organ damage. However, young patients with HT show low awareness of HT compared to older patients. Also, they are more prone to show low treatment adherence despite the good efficacy of the treatment. Other risk factors that hinder HT control among young adults include alcohol intake, smoking, low physical activity, emotional stress, job stress, metabolic syndrome, and obesity. This review aimed to illustrate the suboptimal control status of the young hypertensive population and to propose strategies for improvement.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"29 1","pages":"13"},"PeriodicalIF":4.2,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150511/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9751786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High blood pressure and associated factors among HIV-infected young persons aged 13 to 25 years at selected health facilities in Rwenzori region, western Uganda, September-October 2021. 2021年9月至10月,在乌干达西部鲁文佐里地区选定的卫生设施中,感染艾滋病毒的13至25岁年轻人的高血压及相关因素。
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-04-15 DOI: 10.1186/s40885-022-00230-5
Richard Migisha, Alex Riolexus Ario, Daniel Kadobera, Lilian Bulage, Elizabeth Katana, Alex Ndyabakira, Peter Elyanu, Julius N Kalamya, Julie R Harris

Background: High blood pressure (HBP), including hypertension (HTN), is a predictor of cardiovascular events, and is an emerging challenge in young persons. The risk of cardiovascular events may be further amplified among people living with HIV (PLHIV). We determined the prevalence of HBP and associated factors among PLHIV aged 13 to 25 years in Rwenzori region, western Uganda.

Methods: We conducted a cross-sectional study among PLHIV aged 13 to 25 years at nine health facilities in Kabarole and Kasese districts during September 16 to October 15, 2021. We reviewed medical records to obtain clinical and demographic data. At a single clinic visit, we measured and classified BP as normal (< 120/ < 80 mmHg), elevated (120/ < 80 to 129/ < 80), stage 1 HTN (130/80 to 139/89), and stage 2 HTN (≥ 140/90). We categorized participants as having HBP if they had elevated BP or HTN. We performed multivariable analysis using modified Poisson regression to identify factors associated with HBP.

Results: Of the 1,045 PLHIV, most (68%) were female and the mean age was 20 (3.8) years. The prevalence of HBP was 49% (n = 515; 95% confidence interval [CI], 46%-52%), the prevalence of elevated BP was 22% (n = 229; 95% CI, 26%-31%), and the prevalence of HTN was 27% (n = 286; 95% CI, 25%-30%), including 220 (21%) with stage 1 HTN and 66 (6%) with stage 2 HTN. Older age (adjusted prevalence ratio [aPR], 1.21; 95% CI, 1.01-1.44 for age group of 18-25 years vs. 13-17 years), history of tobacco smoking (aPR, 1.41; 95% CI, 1.08-1.83), and higher resting heart rate (aPR, 1.15; 95% CI, 1.01-1.32 for > 76 beats/min vs. ≤ 76 beats/min) were associated with HBP.

Conclusions: Nearly half of the PLHIV evaluated had HBP, and one-quarter had HTN. These findings highlight a previously unknown high burden of HBP in this setting's young populations. HBP was associated with older age, elevated resting heart rate, and ever smoking; all of which are known traditional risk factors for HBP in HIV-negative persons. To prevent future cardiovascular disease epidemics among PLHIV, there is a need to integrate HBP/HIV management.

背景:高血压(HBP),包括高血压(HTN),是心血管事件的预测因子,是年轻人面临的一个新兴挑战。艾滋病毒感染者(PLHIV)发生心血管事件的风险可能会进一步增加。我们确定了乌干达西部鲁文佐里地区13至25岁hiv感染者中HBP的患病率及其相关因素。方法:我们于2021年9月16日至10月15日在Kabarole和Kasese地区的9个卫生机构对13至25岁的PLHIV进行了横断面研究。我们查阅了医疗记录以获得临床和人口统计数据。在一次诊所访问中,我们测量并将血压分类为正常(结果:1,045例PLHIV患者中,大多数(68%)为女性,平均年龄为20岁(3.8)岁)。HBP患病率为49% (n = 515;95%可信区间[CI], 46%-52%),血压升高的患病率为22% (n = 229;95% CI, 26%-31%), HTN患病率为27% (n = 286;95% CI, 25%-30%),包括220例(21%)HTN期患者和66例(6%)HTN期患者。老年(调整患病率[aPR], 1.21;18-25岁年龄组对13-17岁年龄组的95% CI为1.01-1.44,吸烟史(aPR, 1.41;95% CI, 1.08-1.83)和更高的静息心率(aPR, 1.15;> 76次/分与≤76次/分的95% CI为1.01-1.32,与HBP相关。结论:近一半的PLHIV患者有HBP,四分之一的患者有HTN。这些发现突出表明,在这种情况下,年轻人群中存在以前未知的高高血压负担。HBP与年龄较大、静息心率升高和吸烟有关;所有这些都是已知的hiv阴性患者HBP的传统危险因素。为了预防未来PLHIV中心血管疾病的流行,需要整合HBP/HIV管理。
{"title":"High blood pressure and associated factors among HIV-infected young persons aged 13 to 25 years at selected health facilities in Rwenzori region, western Uganda, September-October 2021.","authors":"Richard Migisha,&nbsp;Alex Riolexus Ario,&nbsp;Daniel Kadobera,&nbsp;Lilian Bulage,&nbsp;Elizabeth Katana,&nbsp;Alex Ndyabakira,&nbsp;Peter Elyanu,&nbsp;Julius N Kalamya,&nbsp;Julie R Harris","doi":"10.1186/s40885-022-00230-5","DOIUrl":"https://doi.org/10.1186/s40885-022-00230-5","url":null,"abstract":"<p><strong>Background: </strong>High blood pressure (HBP), including hypertension (HTN), is a predictor of cardiovascular events, and is an emerging challenge in young persons. The risk of cardiovascular events may be further amplified among people living with HIV (PLHIV). We determined the prevalence of HBP and associated factors among PLHIV aged 13 to 25 years in Rwenzori region, western Uganda.</p><p><strong>Methods: </strong>We conducted a cross-sectional study among PLHIV aged 13 to 25 years at nine health facilities in Kabarole and Kasese districts during September 16 to October 15, 2021. We reviewed medical records to obtain clinical and demographic data. At a single clinic visit, we measured and classified BP as normal (< 120/ < 80 mmHg), elevated (120/ < 80 to 129/ < 80), stage 1 HTN (130/80 to 139/89), and stage 2 HTN (≥ 140/90). We categorized participants as having HBP if they had elevated BP or HTN. We performed multivariable analysis using modified Poisson regression to identify factors associated with HBP.</p><p><strong>Results: </strong>Of the 1,045 PLHIV, most (68%) were female and the mean age was 20 (3.8) years. The prevalence of HBP was 49% (n = 515; 95% confidence interval [CI], 46%-52%), the prevalence of elevated BP was 22% (n = 229; 95% CI, 26%-31%), and the prevalence of HTN was 27% (n = 286; 95% CI, 25%-30%), including 220 (21%) with stage 1 HTN and 66 (6%) with stage 2 HTN. Older age (adjusted prevalence ratio [aPR], 1.21; 95% CI, 1.01-1.44 for age group of 18-25 years vs. 13-17 years), history of tobacco smoking (aPR, 1.41; 95% CI, 1.08-1.83), and higher resting heart rate (aPR, 1.15; 95% CI, 1.01-1.32 for > 76 beats/min vs. ≤ 76 beats/min) were associated with HBP.</p><p><strong>Conclusions: </strong>Nearly half of the PLHIV evaluated had HBP, and one-quarter had HTN. These findings highlight a previously unknown high burden of HBP in this setting's young populations. HBP was associated with older age, elevated resting heart rate, and ever smoking; all of which are known traditional risk factors for HBP in HIV-negative persons. To prevent future cardiovascular disease epidemics among PLHIV, there is a need to integrate HBP/HIV management.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"29 1","pages":"6"},"PeriodicalIF":4.2,"publicationDate":"2023-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9315259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Salty taste test for a low-salt diet to control blood pressure. 低盐饮食控制血压的咸味测试。
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-04-15 DOI: 10.1186/s40885-023-00236-7
Seon-Hee Yang, Jea-Chul Ha, Min-Ji Kim

Background: Reducing salt intake helps prevent complications of cerebrovascular disease. To help patients accept a low-sodium diet, the salty taste test is used to evaluate how much salt an individual actually consumes. The aim of this study was to help patients with hypertension reduce their salt intake by helping them recognize the difference between their subjective perception of saltiness and the objective test results.

Methods: We enrolled workers who visited a local occupational health institution in the period from April to August 2019. Demographic and physical characteristics were recorded. Blood pressure measurement and use of medication were also recorded. A questionnaire was used to investigate whether people liked or disliked salty food, i.e., preference for saltiness, and whether they usually ate salty, normal, or fresh food, i.e., the subjective perception of saltiness. Subsequently, the taste determination kit provided by the Ministry of Food and Drug Safety was used to objectively test saltiness at various salty taste concentrations. The Ministry of Food and Drug Safety program (No. 10-093760) was used as the salty taste judgment tool.

Results: A total of 86 workers were surveyed. Eleven of 18 workers (61.1%) who reported usually eating fresh food actually ate normal or salty food. Thirteen of 37 workers (35.1%) who reported eating normal food actually ate salty food. Thirteen of 31 workers (41.9%) who reported eating salty food actually ate fresh or normal food. Of 46 workers who reported disliking salty food, 14 (30.4%) actually ate salty food, while 20 (43.5%) ate normal food. The subjective perception and preference for saltiness were not significantly correlated with the objective test results (P = ​​0.085 and P = 0.110, respectively). As for the subjective perception and preference for saltiness, Cohen's weighted kappa for the taste judgment result were 0.23 and 0.22, respectively, indicating a low degree of agreement.

Conclusions: In dietary counseling to prevent cerebrovascular and cardiovascular diseases, rather than relying on the subjective perception of saltiness, a salty taste test should be performed such that people can recognize their salty food eating habits through objective evaluation.

背景:减少盐的摄入有助于预防脑血管疾病的并发症。为了帮助病人接受低钠饮食,咸味测试被用来评估一个人实际摄入了多少盐。本研究的目的是通过帮助高血压患者认识到他们对咸味的主观感知与客观测试结果之间的差异,从而帮助他们减少盐的摄入量。方法:选取2019年4 - 8月到当地某职业卫生机构就诊的劳动者为研究对象。记录人口统计学和体格特征。同时记录血压测量和药物使用情况。通过问卷调查人们是否喜欢或不喜欢咸的食物,即对咸的偏好,以及他们通常吃咸的,正常的还是新鲜的食物,即对咸的主观感知。随后,使用食品药品安全部提供的味觉测定试剂盒,客观检测不同咸味浓度下的咸度。使用食品药品安全部项目(编号10-093760)作为咸味判断工具。结果:共调查86名职工。在18名自称经常吃新鲜食物的员工中,有11人(61.1%)实际上吃的是正常或咸的食物。报告饮食正常的37人中,有13人(35.1%)实际上吃的是咸的食物。在31名报告吃咸食物的员工中,有13人(41.9%)实际上吃的是新鲜或正常的食物。在46名不喜欢吃咸食物的员工中,14人(30.4%)吃咸食物,20人(43.5%)吃正常食物。主观对咸味的感知和偏好与客观测试结果无显著相关(P = 0.085, P = 0.110)。对于咸味的主观感知和偏好,味觉判断结果的Cohen加权kappa分别为0.23和0.22,一致性较低。结论:在预防脑血管、心血管疾病的饮食咨询中,不应依赖于对咸味的主观感知,而应进行咸味测试,通过客观评价来认识自己的咸味饮食习惯。
{"title":"Salty taste test for a low-salt diet to control blood pressure.","authors":"Seon-Hee Yang,&nbsp;Jea-Chul Ha,&nbsp;Min-Ji Kim","doi":"10.1186/s40885-023-00236-7","DOIUrl":"https://doi.org/10.1186/s40885-023-00236-7","url":null,"abstract":"<p><strong>Background: </strong>Reducing salt intake helps prevent complications of cerebrovascular disease. To help patients accept a low-sodium diet, the salty taste test is used to evaluate how much salt an individual actually consumes. The aim of this study was to help patients with hypertension reduce their salt intake by helping them recognize the difference between their subjective perception of saltiness and the objective test results.</p><p><strong>Methods: </strong>We enrolled workers who visited a local occupational health institution in the period from April to August 2019. Demographic and physical characteristics were recorded. Blood pressure measurement and use of medication were also recorded. A questionnaire was used to investigate whether people liked or disliked salty food, i.e., preference for saltiness, and whether they usually ate salty, normal, or fresh food, i.e., the subjective perception of saltiness. Subsequently, the taste determination kit provided by the Ministry of Food and Drug Safety was used to objectively test saltiness at various salty taste concentrations. The Ministry of Food and Drug Safety program (No. 10-093760) was used as the salty taste judgment tool.</p><p><strong>Results: </strong>A total of 86 workers were surveyed. Eleven of 18 workers (61.1%) who reported usually eating fresh food actually ate normal or salty food. Thirteen of 37 workers (35.1%) who reported eating normal food actually ate salty food. Thirteen of 31 workers (41.9%) who reported eating salty food actually ate fresh or normal food. Of 46 workers who reported disliking salty food, 14 (30.4%) actually ate salty food, while 20 (43.5%) ate normal food. The subjective perception and preference for saltiness were not significantly correlated with the objective test results (P = ​​0.085 and P = 0.110, respectively). As for the subjective perception and preference for saltiness, Cohen's weighted kappa for the taste judgment result were 0.23 and 0.22, respectively, indicating a low degree of agreement.</p><p><strong>Conclusions: </strong>In dietary counseling to prevent cerebrovascular and cardiovascular diseases, rather than relying on the subjective perception of saltiness, a salty taste test should be performed such that people can recognize their salty food eating habits through objective evaluation.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"29 1","pages":"12"},"PeriodicalIF":4.2,"publicationDate":"2023-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105384/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9315260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Hypertension
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1